The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage | Zendy

Rikke Hjortebjerg | Zendy; Esben Laugesen | Zendy; Pernille Høyem | Zendy; Claus Oxvig | Zendy; Brian StausbølGrøn | Zendy; Søren Tang Knudsen | Zendy; Won Yong Kim | Zendy; Per Løgstrup Poulsen | Zendy; Troels Krarup Hansen | Zendy; Mette Bjerre | Zendy; Jan Frystyk | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage

Author(s) -

Rikke Hjortebjerg,

Esben Laugesen,

Pernille Høyem,

Claus Oxvig,

Brian StausbølGrøn,

Søren Tang Knudsen,

Won Yong Kim,

Per Løgstrup Poulsen,

Troels Krarup Hansen,

Mette Bjerre,

Jan Frystyk

Publication year - 2017

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje-16-0940

Subject(s) - medicine , subclinical infection , pulse wave velocity , endocrinology , type 2 diabetes , diabetes mellitus , arterial stiffness , cardiology , insulin like growth factor , growth factor , blood pressure , receptor

Perturbations in the insulin-like growth factor (IGF) system may contribute to the accelerated cardiovascular disease (CVD) that occurs in patients with type 2 diabetes (T2D). However, it remains unknown whether the IGF system is also involved in the development of early, subclinical CVD. We characterised the IGF system in T2D patients and matched controls and examined the associations with markers of subclinical target organ damage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research